Evercore Wealth Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Evercore Wealth Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,702	Closed	-$44K	–	1118
2016 Q3	$44K	Hold	4,702	–	–	﹤0.01%	626
2016 Q2	$30K	Hold	4,702	–	–	﹤0.01%	689
2016 Q1	$26K	Hold	4,702	–	–	﹤0.01%	683
2015 Q4	$26K	Hold	4,702	–	–	﹤0.01%	721
2015 Q3	$40K	Sell	4,702 -38,386	-89%	-$650K	﹤0.01%	625
2015 Q2	$651K	Hold	43,088	–	–	0.03%	245
2015 Q1	$690K	Hold	43,088	–	–	0.03%	233
2014 Q4	$768K	Hold	43,088	–	–	0.04%	197
2014 Q3	$432K	Buy	43,088 +38,386	+816%	+$465K	0.02%	286
2014 Q2	$73K	Hold	4,702	–	–	﹤0.01%	558
2014 Q1	$87K	Buy	+4,702	New	+$94.2K	﹤0.01%	512

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Evercore Wealth Management's PETX Position: Q4 2016 in Review

Evercore Wealth Management sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2016, closing a stake of 4,702 shares — an estimated $44K sold.

Evercore Wealth Management first reported a position in PETX in Q1 2014 and held it in 11 quarters. The position peaked at $768K in Q4 2014. 107 funds tracked by Wall St. Rank hold PETX as of Q4 2016.

Evercore Wealth Management reported no remaining Aratana Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
Evercore Wealth Management sold 4,702 Aratana Therapeutics, Inc. shares in Q4 2016, an estimated $44K.
Evercore Wealth Management first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 11 quarters.
Evercore Wealth Management's Aratana Therapeutics, Inc. position peaked at $768K in Q4 2014.
107 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2016.

Based on Evercore Wealth Management's 13F filing for Q4 2016, filed 8 Feb 2017.